Literature DB >> 23536127

Animal models in obesity and hypertension.

Gabriella Segal-Lieberman1, Talma Rosenthal.   

Abstract

Although obesity is a well-known risk factor for hypertension, the mechanisms by which hypertension develops in obese patients are not entirely clear. Animal models of obesity and their different susceptibilities to develop hypertension have revealed some of the mechanisms linking obesity and hypertension. Adipose tissue is an endocrine organ secreting hormones that impact blood pressure, such as elements of the renin-angiotensin system whose role in hypertension have been established. In addition, the appetite-suppressing adipokine leptin activates the sympathetic nervous system via the melanocortin system, and this activation, especially in the kidney, increases blood pressure. Leptin secretion from adipocytes is increased in most models of obesity due to leptin resistance, although the resistance is often selective to the anorexigenic effect, while the susceptibility to the hypertensive effect remains intact. Understanding the pathways by which obesity contributes to increased blood pressure will hopefully pave the way to and better define the appropriate treatment for obesity-induced hypertension.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23536127     DOI: 10.1007/s11906-013-0338-3

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  36 in total

1.  The brain Renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance.

Authors:  Justin L Grobe; Connie L Grobe; Terry G Beltz; Scott G Westphal; Donald A Morgan; Di Xu; Willem J de Lange; Huiping Li; Koji Sakai; Daniel R Thedens; Lisa A Cassis; Kamal Rahmouni; Allyn L Mark; Alan Kim Johnson; Curt D Sigmund
Journal:  Cell Metab       Date:  2010-11-03       Impact factor: 27.287

2.  Melanocortin 3/4 receptors in paraventricular nucleus modulate sympathetic outflow and blood pressure.

Authors:  Peng Li; Bai-Ping Cui; Ling-Li Zhang; Hai-Jian Sun; Tong-Yan Liu; Guo-Qing Zhu
Journal:  Exp Physiol       Date:  2012-08-07       Impact factor: 2.969

3.  Non-communicable disease: a welcome and long needed addition to the WHO's 2012 World Heath Statistics.

Authors:  Jonathan Owen; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

4.  Azilsartan treatment improves insulin sensitivity in obese spontaneously hypertensive Koletsky rats.

Authors:  M Zhao; Y Li; J Wang; K Ebihara; X Rong; K Hosoda; T Tomita; K Nakao
Journal:  Diabetes Obes Metab       Date:  2011-12       Impact factor: 6.577

Review 5.  Role of leptin and central nervous system melanocortins in obesity hypertension.

Authors:  Alexandre A da Silva; Jussara M do Carmo; John E Hall
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-03       Impact factor: 2.894

6.  Effects of endurance exercise training, metformin, and their combination on adipose tissue leptin and IL-10 secretion in OLETF rats.

Authors:  Nathan T Jenkins; Jaume Padilla; Arturo A Arce-Esquivel; David S Bayless; Jeffrey S Martin; Heather J Leidy; Frank W Booth; R Scott Rector; M Harold Laughlin
Journal:  J Appl Physiol (1985)       Date:  2012-09-27

7.  Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors.

Authors:  Aurelie Nguyen Dinh Cat; Ana M Briones; Glaucia E Callera; Alvaro Yogi; Ying He; Augusto C Montezano; Rhian M Touyz
Journal:  Hypertension       Date:  2011-07-25       Impact factor: 10.190

Review 8.  Animals models of MCH function and what they can tell us about its role in energy balance.

Authors:  Pavlos Pissios
Journal:  Peptides       Date:  2009-05-15       Impact factor: 3.750

Review 9.  The adipose renin-angiotensin system: role in cardiovascular disease.

Authors:  Sean Thatcher; Frederique Yiannikouris; Manisha Gupte; Lisa Cassis
Journal:  Mol Cell Endocrinol       Date:  2009-04-29       Impact factor: 4.102

10.  Correlation of renin angiotensin and aldosterone system activity with subcutaneous and visceral adiposity: the framingham heart study.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Ramachandran S Vasan; Martin G Larson; Udo Hoffmann; Thomas J Wang; Caroline S Fox
Journal:  BMC Endocr Disord       Date:  2012-04-04       Impact factor: 2.763

View more
  4 in total

1.  Combined effect of hyperuricemia and overweight/obesity on the prevalence of hypertension among US adults: result from the National Health and Nutrition Examination Survey.

Authors:  G-M Han; S Gonzalez; D DeVries
Journal:  J Hum Hypertens       Date:  2014-05-01       Impact factor: 3.012

2.  Neural circuitry underlying the central hypertensive action of nesfatin-1: melanocortins, corticotropin-releasing hormone, and oxytocin.

Authors:  Gina L C Yosten; Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-03-05       Impact factor: 3.619

Review 3.  Cancer and comorbidity: The role of leptin in breast cancer and associated pathologies.

Authors:  Amitabha Ray
Journal:  World J Clin Cases       Date:  2018-10-26       Impact factor: 1.337

Review 4.  Analysis of energy expenditure in diet-induced obese rats.

Authors:  Houssein Assaad; Kang Yao; Carmen D Tekwe; Shuo Feng; Fuller W Bazer; Lan Zhou; Raymond J Carroll; Cynthia J Meininger; Guoyao Wu
Journal:  Front Biosci (Landmark Ed)       Date:  2014-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.